Pharmacokinetic Evaluation of Testosterone Gel (1%)

Constitutional Delay in Growth and Puberty (CDGP) Clinical Trial

Official title: Pharmacokinetic Evaluation of Testosterone Gel (1%) in Prepubertal Boys of Adolescent Age

Status Completed

Clinical Trial Summary

Measure and evaluate the level of testosterone in blood, and determine the safety and tolerability following daily applications of testosterone gel. Subjects who complete this trial may participate in the extension part (UMD-01-080E).

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Constitutional Delay in Growth and Puberty (CDGP)
• Hypogonadism
• Primary or Secondary Hypogonadism

• NCT number: NCT00193700
• Study type: Interventional
• Source: Solvay Pharmaceuticals
• Status: Completed
• Phase: Phase 1
• Start date: August 2002